BTS
CELG

BB&T Securities’s Celgene Corp CELG Stock Holding History

BB&T Securities’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,500
Closed -$364K – 1542
2017
Q3 		$364K Sell
2,500
-2,500
-50% -$341K ﹤0.01% 1088
2017
Q2 		$649K Buy
+5,000
New +$613K 0.01% 888

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BB&T Securities's CELG Position: Q3 2019 in Review

BB&T Securities reduced its Celgene Corp (CELG) stake by 8.7% in Q3 2019, selling an estimated $272K and leaving 30,207 shares worth $3M. The position accounts for 0.03% of the portfolio, ranked #483.

BB&T Securities first reported a position in CELG in Q3 2013 and has held it in 25 quarters since. The position peaked at $7.07M in Q2 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • BB&T Securities held 30,207 shares of Celgene Corp worth $3M as of Q3 2019.
  • BB&T Securities sold 2,863 Celgene Corp shares in Q3 2019, an estimated $272K.
  • Celgene Corp made up 0.03% of BB&T Securities's portfolio in Q3 2019, its #483 holding.
  • BB&T Securities first reported a position in Celgene Corp in Q3 2013 and has held it in 25 quarters since.
  • BB&T Securities's Celgene Corp position peaked at $7.07M in Q2 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.